Efficacy and safety of XELOX and FOLFOX6 adjuvant chemotherapy following radical total gastrectomy

Oncology Letters

Volumn 3, Issue 4, 2012, Pages 781-786

  Chen, Shi ^a   Feng, Xingyu ^a   Li, Yuanfang ^a   Yuan, Xiuhong ^a   Zhou, Zhiwei ^a   Chen, Yingbo ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

5 fluorouracil; Capecitabine; Gastric cancer; Oxaliplatin; Radical total gastrectomy

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; ADVANCED CANCER; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLERGY; ALOPECIA; ANOREXIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CREATININE BLOOD LEVEL; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; FOLLOW UP; GASTRECTOMY; HAND FOOT SYNDROME; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROTOXICITY; NEUTROPENIA; OUTCOME ASSESSMENT; PHLEBITIS; RETROSPECTIVE STUDY; SIDE EFFECT; STOMACH CANCER; SURVIVAL RATE; THROMBOCYTOPENIA; UREA NITROGEN BLOOD LEVEL; VOMITING;

EID: 84863181067     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.577     Document Type: Article

References (23)

1. Hazard L, O'Connor J and Scaife C: Role of radiation therapy in gastric adenocarcinoma. World J Gastroenterol 12: 1511-1520, 2006.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics. CA Cancer J Clin 57: 43-66, 2007.
3. Crew KD and Neugut AI: Epidemiology of gastric cancer. World J Gastroenterol 12: 354-362, 2006.
4. Zhan YQ, Li W, Sun XW, et al: Long-term results of surgical treatment of stomach cancer: clinical experience of forty years from Sun Yat-sen University Cancer Center. Zhonghua Wai Ke Za Zhi 43: 1109-1113, 2005 (In Chinese).
5. Macdonald JS, Smalley SR, Benedetti J, et al: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345: 725-730, 2001.
6. Cunningham D, Allum WH, Stenning SP, et al: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355: 11-20, 2006.
7. Sakuramoto S, Sasako M, Yamaguchi T, et al: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357: 1810-1820, 2007.
8. Espat NJ and Karpeh M: Reconstruction following total gastrectomy: a review and summary of the randomized prospective clinical trials. Surg Oncol 7: 65-69, 1998.
9. Stael von Holstein C, Walther B, Ibrahimbegovic E and Akesson B: Nutritional status after total and partial gastrectomy with Roux-en-Y reconstruction. Br J Surg 78: 1084-1087, 1991.
10. Gockel I, Pietzka S and Junginger T: Quality of life after subtotal resection and gastrectomy for gastric cancer. Chirurg 76: 250-257, 2005 (In German).
11. Wu LL, Liang H, Zhang RP, Pan Y and Wang BG: Comparative study on four different reconstruction procedures after total gastrectomy. Zhonghua Wei Chang Wai Ke Za Zhi 13: 895-898, 2010 (In Chinese).
12. Yoo CH, Sohn BH, Han WK and Pae WK: Long-term results of proximal and total gastrectomy for adenocarcinoma of the upper third of the stomach. Cancer Res Treat 36: 50-55, 2004.
13. Wei HB, Wei B, Zheng ZH, et al: Comparative study on three types of alimentary reconstruction after total gastrectomy. J Gastrointest Surg 12: 1376-1382, 2008.
14. Park YH, Kim BS, Ryoo BY and Yang SH: A phase II study of capecitabine plus 3-weekly oxaliplatin as first-line therapy for patients with advanced gastric cancer. Br J Cancer 94: 959-963, 2006.
15. Qian J, Qin SK, Mei JF, Chen YX, Shao ZJ and He ZM: Oxaliplatin plus capecitabine as a second line chemotherapy for patients with advanced gastric cancer. Zhonghua Zhong Liu Za Zhi 26: 746-748, 2004 (In Chinese).
16. Luo FR, Wyrick SD and Chaney SG: Comparative neurotoxicity of oxaliplatin, ormaplatin, and their biotransformation products utilizing a rat dorsal root ganglia in vitro explant culture model. Cancer Chemother Pharmacol 44: 29-38, 1999.
17. De Gramont A, Bosset JF, Milan C, et al: Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. J Clin Oncol 15: 808-815, 1997.
18. Lu GC, Fang F and Li DC: Efficacy and toxicity analysis of XELOX and FOLFOX4 regimens as adjuvant chemotherapy for stage III colorectal cancer. Zhonghua Zhong Liu Za Zhi 32: 152-155, 2010 (In Chinese).
19. Dong NN, Wang MY, Zhang Q and Liu ZF: Oxaliplatin combined with capecitabine as first-line chemotherapy for patients with advanced gastric cancer. Ai Zheng 28: 412-415, 2009 (In Chinese).
20. Jucgla A and Sais G: Diagnosis in oncology. Hand-foot syndrome. J Clin Oncol 15: 3164, 1997.
21. Zhang RX, Wu XJ, Lu SX, Pan ZZ, Wan DS and Chen G: The effect of COX-2 inhibitor on capecitabine-induced hand-foot syndrome in patients with stage II/III colorectal cancer: a phase II randomized prospective study. J Cancer Res Clin Oncol 137: 953-7, 2011.
22. Kamil M, Haron M, Yosuff N, Khalid I and Azman N: High frequency of hand foot syndrome with capecitabine. J Coll Physicians Surg Pak 20: 421-422, 2010.
23. Ott K, Lordick F, Blank S and Buchler M: Gastric cancer: surgery in 2011. Langenbecks Arch Surg 396: 743-758, 2011.